Director, Commercial Analytics & Information

Summit Therapeutics•Princeton, NJ

20h•$203,000 - $253,000•Onsite

About The Position

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Location: Princeton, NJ Overview of Role: The Director, Commercial Analytics & Information turns Summit's commercial data into decisions. This role owns launch analytics, performance reporting, dashboards, and the field-facing insight products that tell Sales and Marketing what is working and what is not. The role sets the definitions behind every commercial metric and is the final word on what a number means, so that Sales, Marketing, Finance, and Commercial Operations are all working from the same figure. This leader consumes the data assets owned by Commercial Data Management & Strategy and partners with Business Information on the tools that deliver analysis. Because ivonescimab is an intravenous buy-and-bill product, this role must be able to build a credible performance picture from purchase and claims data rather than from prescription data, and must be explicit about what that picture can and cannot show.

Requirements

Bachelor's degree in a quantitative, business, or life sciences field.
Minimum of 10+ years of commercial analytics experience within pharmaceuticals or biotechnology industry
Product launch analytics experience is required.
Deep fluency with pharmaceutical commercial data assets, including specialty distributor and specialty pharmacy data, claims data, and patient-level data.
Advanced skills in Excel, SQL, and at least one business intelligence platform such as Power BI or Tableau.
Experience supporting incentive compensation goal setting.
Excellent written and verbal communication skills, with a demonstrated ability to explain analytical findings simply and confidently to senior leaders.
Ability to thrive in a fast-paced, dynamic environment and adapt to changing priorities.

Nice To Haves

Graduate degree preferred.
Oncology launch experience is strongly preferred.
People management experience is strongly preferred.
Experience building performance analytics for an intravenous, buy-and-bill product is strongly preferred.

Responsibilities

Own the commercial reporting and analytics package, including the launch dashboard, national and regional performance reporting, and the field-facing report set.
Own the definition of every commercial metric and maintain the definitions document that Sales, Marketing, Finance, and Commercial Operations all work from.
Build the launch analytics framework, including leading indicators that will show whether the launch is on track before revenue data can confirm it.
Deliver analytics supporting targeting and segmentation, call planning, and field resource allocation, in partnership with Sales Operations and Marketing.
Provide the analytical basis for incentive compensation goal setting, in partnership with Sales Operations and Finance.
Build and maintain the analytics tooling and self-service reporting layer, in partnership with Business Information.
Deliver insight rather than data. Explain what changed, why it changed, and what to do about it, in language a commercial leader can act on.
Set the analytical standards the eleven Regional Business Managers work to, so regional analysis rolls up consistently.
State clearly and in writing the limitations of the available data, including what buy-and-bill purchase data cannot tell the organization about patient-level demand.
Apply claims, EHR, lab, and alternative data sources – including digital/omnichannel, payer, and hub – to support patient journey modeling, segmentation, and drivers-of-business analysis in partnership with Marketing.
Leverage AI tools and analog research to surface forecast-relevant insights and support cross-functional decision making in collaboration with the Director, Forecasting and Commercial Data & Technology.
All other duties as assigned